Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway
International Journal of Oncology · 19.11.2024 · 66 (1)
DOI: 10.3892/ijo.2024.5708 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Oncology, online erschienen am 19.11.2024. Verfasst von Qian Kong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510000, P.R. China. Hauptthemen laut MEDLINE: Sirtuin 1, Cytarabine, Leukemia, Myeloid, Acute, Ferroptosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510000, P.R. China.
- Department of Stomatology, The Third Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510000, P.R. China.
Zitieren
APA
Kong, Q., Liang, Q., Tan, Y., Luo, X., Ling, Y., Li, X., Cai, Y., & Chen, H. (2024). Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway. International Journal of Oncology, 66(1). https://doi.org/10.3892/ijo.2024.5708
Vancouver
Kong Q, Liang Q, Tan Y, Luo X, Ling Y, Li X, et al. Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway. International Journal of Oncology. 2024;66(1). doi:10.3892/ijo.2024.5708
BibTeX
@article{Kong2024,
author = {Kong, Qian and Liang, Qixiang and Tan, Yinli and Luo, Xiangqin and Ling, Yesheng and Li, Xiaofeng and Cai, Yun and Chen, Huiqin},
title = {Induction of ferroptosis by SIRT1 knockdown alleviates cytarabine resistance in acute myeloid leukemia by activating the HMGB1/ACSL4 pathway},
journal = {International Journal of Oncology},
year = {2024},
volume = {66},
number = {1},
doi = {10.3892/ijo.2024.5708}
}
EUVIMED